Literature DB >> 2935076

Susceptibility of clinical isolates of Campylobacter pyloridis to 11 antimicrobial agents.

C A McNulty, J Dent, R Wise.   

Abstract

The activities of 11 antimicrobial agents, including two bismuth salts, against 70 strains of Campylobacter pyloridis isolated from gastric biopsy specimens were tested. The isolates were very susceptible to penicillin (the MIC for 90% of the strains tested [MIC90] was 0.03 microgram/ml), erythromycin, cefoxitin (MIC90, 0.12 microgram/ml), gentamicin, and ciprofloxacin (MIC90, 0.25 microgram/ml). The bismuth salts and nalidixic acid had moderate activity (MIC90, 16 to 64 micrograms/ml). Twenty percent of the isolates were resistant to metronidazole (MIC, greater than 1 micrograms/ml), and all were resistant to sulfamethoxazole and trimethoprim (MIC90, greater than 256 micrograms/ml).

Entities:  

Mesh:

Substances:

Year:  1985        PMID: 2935076      PMCID: PMC180341          DOI: 10.1128/AAC.28.6.837

Source DB:  PubMed          Journal:  Antimicrob Agents Chemother        ISSN: 0066-4804            Impact factor:   5.191


  16 in total

1.  Campylobacter enteritis: a "new" disease.

Authors:  M B Skirrow
Journal:  Br Med J       Date:  1977-07-02

2.  Antibiotic sensitivity of "Campylobacter pylori".

Authors:  G Kasper; N Dickgiesser
Journal:  Eur J Clin Microbiol       Date:  1984-10       Impact factor: 3.267

3.  Susceptibility of clinical isolates of Campylobacter jejuni to sixteen antimicrobial agents.

Authors:  J Michel; M Rogol; D Dickman
Journal:  Antimicrob Agents Chemother       Date:  1983-05       Impact factor: 5.191

4.  Susceptibility of Campylobacter fetus subsp. jejuni to twenty-nine antimicrobial agents.

Authors:  R Vanhoof; M P Vanderlinden; R Dierickx; S Lauwers; E Yourassowsky; J P Butzler
Journal:  Antimicrob Agents Chemother       Date:  1978-10       Impact factor: 5.191

5.  Antimicrobial susceptibility of Campylobacter jejuni isolated from humans with diarrhoea and from healthy chickens.

Authors:  A Svedhem; B Kaijser; E Sjögren
Journal:  J Antimicrob Chemother       Date:  1981-03       Impact factor: 5.790

6.  Antinauseant and antiemetic properties of bismuth subsalicylate in dogs and humans.

Authors:  M M Goldenberg; L J Honkomp; C S Davis
Journal:  J Pharm Sci       Date:  1976-09       Impact factor: 3.534

Review 7.  The pharmacology of tri-potassium di-citrato bismuthate (TDB).

Authors:  T R Wilson
Journal:  Postgrad Med J       Date:  1975       Impact factor: 2.401

8.  Evaluation of bismuth subsalicylate in relieving symptoms of indigestion.

Authors:  F J Hailey; J H Newsom
Journal:  Arch Intern Med       Date:  1984-02

9.  Enhancing effect on alkalinization of the medium on the activity of erythromycin against gram-negative bacteria.

Authors:  L D Sabath; V Lorian; D Gerstein; P B Loder; M Finland
Journal:  Appl Microbiol       Date:  1968-09

10.  Difference in relapse rates of duodenal ulcer after healing with cimetidine or tripotassium dicitrato bismuthate.

Authors:  D F Martin; D Hollanders; S J May; M M Ravenscroft; D E Tweedle; J P Miller
Journal:  Lancet       Date:  1981-01-03       Impact factor: 79.321

View more
  51 in total

Review 1.  Role of Helicobacter pylori in duodenal ulcer.

Authors:  E A Rauws
Journal:  Drugs       Date:  1992-12       Impact factor: 9.546

2.  Helicobacter pylori uptake and efflux: basis for intrinsic susceptibility to antibiotics in vitro.

Authors:  J E Bina; R A Alm; M Uria-Nickelsen; S R Thomas; T J Trust; R E Hancock
Journal:  Antimicrob Agents Chemother       Date:  2000-02       Impact factor: 5.191

3.  Antibiotic susceptibility of Helicobacter pylori clinical isolates: comparative evaluation of disk-diffusion and E-test methods.

Authors:  K K Mishra; S Srivastava; A Garg; A Ayyagari
Journal:  Curr Microbiol       Date:  2006-09-12       Impact factor: 2.188

4.  Lansoprazole, a novel benzimidazole proton pump inhibitor, and its related compounds have selective activity against Helicobacter pylori.

Authors:  T Iwahi; H Satoh; M Nakao; T Iwasaki; T Yamazaki; K Kubo; T Tamura; A Imada
Journal:  Antimicrob Agents Chemother       Date:  1991-03       Impact factor: 5.191

Review 5.  Helicobacter pylori and peptic ulcers: the present position.

Authors:  S Moss; J Calam
Journal:  Gut       Date:  1992-03       Impact factor: 23.059

6.  Susceptibility of Helicobacter pylori to metronidazole.

Authors:  M López-Brea; E Martín; C López-Lavid; J C Sanz
Journal:  Eur J Clin Microbiol Infect Dis       Date:  1991-12       Impact factor: 3.267

7.  In vitro activities of new quinolones against Helicobacter pylori.

Authors:  M Carbone; M T Fera; V Cecchetti; O Tabarrini; E Losi; V Cusumano; G Teti
Journal:  Antimicrob Agents Chemother       Date:  1997-12       Impact factor: 5.191

8.  Susceptibility of Campylobacter pyloridis to three macrolide antibiotics (erythromycin, roxithromycin [RU 28965], and CP 62,993) and rifampin.

Authors:  S Czinn; H Carr; S Aronoff
Journal:  Antimicrob Agents Chemother       Date:  1986-08       Impact factor: 5.191

9.  Assessment of metronidazole susceptibility in Helicobacter pylori: statistical validation and error rate analysis of breakpoints determined by the disk diffusion test.

Authors:  S Chaves; M Gadanho; R Tenreiro; J Cabrita
Journal:  J Clin Microbiol       Date:  1999-05       Impact factor: 5.948

10.  Comparative susceptibilities of Campylobacter pylori to norfloxacin and other agents.

Authors:  D L Shungu; D R Nalin; R H Gilman; H H Gadebusch; A T Cerami; C Gill; B Weissberger
Journal:  Antimicrob Agents Chemother       Date:  1987-06       Impact factor: 5.191

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.